German Science & Technology Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on German Science & Technology Today.

Press releases published on October 26, 2026

Oct. 26, 2026

INDUSTRY LEADERS LAUNCH WORLD’S FIRST MARITIME-SPECIFIC CYBER VULNERABILITIES DATABASE

Indeterminate EIN Presswire

Oct. 26, 2026

A More Human Conversation About Artificial Intelligence with Replika

Indeterminate EIN Presswire

Oct. 26, 2026

Yard Force to Showcase 58V REVO and Robotic Lawn Mowers at EIMA 2026

Indeterminate EIN Presswire

Oct. 26, 2026

leagend Launches the World's First Supercapacitor Jump Starter for Hybrid Vehicles in the Automotive Aftermarket

Indeterminate EIN Presswire

Oct. 26, 2026

New Framework Aims to Identify Antibiotic Resistance Risks Before Clinical Trials

Indeterminate EIN Presswire

Oct. 26, 2026

Instinctools Places in Top 10 Across Six Categories in Feedbax's 2026 Rankings

Indeterminate EIN Presswire

Oct. 26, 2026

SHAPING THE RESPONSIBLE FUTURE OF INTELLIGENT AND AUTONOMOUS DEFENCE SYSTEMS

Indeterminate EIN Presswire

Oct. 26, 2026

Top 10 CNC Machined Precision Metal Mechanical Parts Manufacturers in 2026: Advancing Green Energy Tech

Indeterminate EIN Presswire

Oct. 26, 2026

Five Reputable High-Torque Gear Reducer Companies in China 2026: Driving Industrial Efficiency

Indeterminate EIN Presswire

Oct. 26, 2026

Top 10 Analog FPV Camera Manufacturers in 2026: Advancing Immersive First-Person View Tech

Indeterminate EIN Presswire

Oct. 26, 2026

leagend JS300 PRO: A Smarter Way to Extend Vehicle Battery Service Life Debuts on Kickstarter

Indeterminate EIN Presswire

Oct. 26, 2026

From Great Chinese Gifts to Global Brand Awareness: Winseed Shares Holiday GEO Strategy at GGE Expo

Indeterminate GlobeNewswire

Oct. 26, 2026

Quantum Cyber Invited to Present Quantum Antenna Technology at QuantumCT Quantum Sensing Convening

Indeterminate GlobeNewswire

Oct. 26, 2026

BioNTech und DualityBio geben Topline-Ergebnisse der globalen klinischen Phase-3-Studie DYNASTY-Breast02 für Trastuzumab Pamirtecan bei metastasiertem HR+/HER2-low-Brustkrebs bekannt

Indeterminate GlobeNewswire

Oct. 26, 2026

BioNTech and DualityBio Announce Topline Results of the DYNASTY-Breast02 Global Phase 3 Clinical Trial Evaluating Trastuzumab Pamirtecan in HR+/HER2-low Metastatic Breast Cancer

Indeterminate GlobeNewswire